The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...
The US Food and Drug Administration has approved Cobenfy, also known as KarXT, a new schizophrenia treatment. The drug was ...
Cobenfy offers a new option to manage this challenging condition.” Related: Early Signs and Symptoms of Schizophrenia Cobenfy combines xanomeline, an experimental drug for Alzheimer’s disease ...
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S.